Metagil-GV2
Composition: Glimepiride 2 mg + Voglibose 0.2 mg + Metformin 500 mg SR
Metagil GV2 is a higher-strength triple combination of Glimepiride 2 mg, Voglibose 0.2 mg, and Metformin 500 mg. This formulation provides strong and comprehensive control of Type 2 Diabetes by improving insulin secretion, slowing carbohydrate absorption, and improving insulin sensitivity throughout the day. It is suitable for patients requiring more potent glucose-lowering action, especially those with high post-meal sugar levels.
Uses:
- Advanced control of Type 2 Diabetes
- Management of high postprandial sugar levels
- Reduction of HbA1c
- For patients needing stronger therapy beyond dual medications
Side Effects:
- Low blood sugar
- Bloating, gas, abdominal discomfort
- Mild nausea or diarrhea
- Dizziness, sweating
- Rare: lactic acidosis
Other Details:
- Take just before meals for best effect
- Regular monitoring of sugar advised
- Avoid alcohol
- Not suitable for patients with severe renal issues
